Whatever size your firm, it’s essential to deliver on client expectations.

But what if your client’s success depends on you delivering on a whole catalog of work that would typically take months, in less than two weeks?

That’s exactly the scenario QUINTA-ANALYTICA faced recently with a global name client that depended on them, quite literally, for the successful go-to-market of their latest drug.

An extraordinary effort by one or two people often plays a part in many projects, but a determined spirit and get-it-done attitude by multiple teams is far less common. In this case, it was a must! Read about the challenge, and how the Quinta team brilliantly overcame it, in the PDF here.

Two decades of experience, two decades of delivering on their promise of bringing client’s drugs to market on time, and two decades of unrivaled quality in each and every interaction.

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.